chr1-205241790-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014858.4(TMCC2):c.493G>A(p.Ala165Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000225 in 1,600,608 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014858.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMCC2 | NM_014858.4 | c.493G>A | p.Ala165Thr | missense_variant | 2/5 | ENST00000358024.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMCC2 | ENST00000358024.8 | c.493G>A | p.Ala165Thr | missense_variant | 2/5 | 1 | NM_014858.4 | P3 | |
TMCC2 | ENST00000545499.5 | c.259G>A | p.Ala87Thr | missense_variant | 2/5 | 2 | A1 | ||
TMCC2 | ENST00000495538.5 | n.724G>A | non_coding_transcript_exon_variant | 2/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000231 AC: 5AN: 216552Hom.: 0 AF XY: 0.0000167 AC XY: 2AN XY: 119924
GnomAD4 exome AF: 0.0000200 AC: 29AN: 1448290Hom.: 0 Cov.: 31 AF XY: 0.0000194 AC XY: 14AN XY: 720054
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2024 | The c.493G>A (p.A165T) alteration is located in exon 2 (coding exon 2) of the TMCC2 gene. This alteration results from a G to A substitution at nucleotide position 493, causing the alanine (A) at amino acid position 165 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at